Myelodysplastic Syndromes: all 2,165 studies

Page 22 of 22. Open to participants first (322), then studies with results posted, then the rest; newest registration first within each.

• Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003961Phase 2
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003960Phase 2
• Vaccine Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003959Phase 1
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseCompletedNCT00003913Phase 2
• Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
• Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaStatus unknownNCT00003885Phase 2
• Combination Chemotherapy in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003827Phase 2
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3
• Genetic Study of Children With Soft Tissue Sarcoma or RhabdomyosarcomaCompletedNCT00003793
• Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00003790
• Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00003693Phase 1
• Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
• Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003681Phase 2
• Topotecan in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003675Phase 2
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic DiseasesCompletedNCT00003662Phase 2
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003661Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaCompletedNCT00003619Phase 1/2
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaStatus unknownNCT00003602Phase 3
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic SyndromeCompletedNCT00003593Phase 3
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersCompletedNCT00003572Phase 2
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaCompletedNCT00003436Phase 3
• Amifostine Plus Topotecan in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003415Phase 1/2
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerCompletedNCT00003408Phase 2
• Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CMLWithdrawnNCT00003407Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerCompletedNCT00003406Phase 1/2
• Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003398Phase 4
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003396Phase 2
• Decitabine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003361Phase 2
• Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic ConditionsCompletedNCT00003336Phase 2
• Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerCompletedNCT00003335Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003331Phase 1
• Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerCompletedNCT00003243Phase 1
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic LymphomaCompletedNCT00003187Phase 2/3
• Bryostatin 1 in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003171Phase 2
• Amifostine in Treating Patients With Advanced Myelodysplastic SyndromeStatus unknownNCT00003123Phase 2
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2
• Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsCompletedNCT00003107Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Advanced CancerCompletedNCT00003082Phase 1
• Amifostine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003048Phase 2
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeStatus unknownNCT00002989Phase 3
• Decitabine in Treating Patients With Melanoma or Other Advanced CancerCompletedNCT00002980Phase 1
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaStatus unknownNCT00002926Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00002890Phase 1
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaCompletedNCT00002833Phase 2
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00002832Phase 1/2
• Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerCompletedNCT00002809Phase 2
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002805Phase 2
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002800Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
• Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantWithdrawnNCT00002790Phase 1/2
• Interleukin-2 in Treating Patients With Myelodysplastic SyndromeCompletedNCT00002746Phase 1
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic CancerCompletedNCT00002742Phase 3
• T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
• Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic SyndromeCompletedNCT00002547Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002517Phase 3
• Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerCompletedNCT00002504Phase 2
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2
• The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersCompletedNCT00001873Phase 2
• A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
• HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological MalignanciesCompletedNCT00001748Phase 1
• Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older AdultsCompletedNCT00001637Phase 2
• Bone Marrow Transplant Studies for Safe and Effective Treatment of LeukemiaCompletedNCT00001623Not applicable
• Cord Blood Stem Cell Transplantation Study (COBLT)CompletedNCT00000603Phase 2
• T-Cell Depletion in Unrelated Donor Marrow TransplantationCompletedNCT00000591Phase 3

← Myelodysplastic Syndromes overview